New South Wales to trial COVID-19 vaccine passport app in October

The Australian state of New South Wales will begin a two-week trial of a COVID-19 vaccine passport app on 6 October.

This comes ahead of the possible reopening of hospitality venues on 11 October on the condition that the state fully vaccinates 70% of its population.


Sydney Morning Herald reported that the vaccine passport app is being developed by Service NSW to simplify the check-in process at pubs, restaurants and other venues, so people do not need to move through separate apps for QR codes and proof of vaccination.

The app will integrate the check-in features in the Service NSW app with the proof of COVID-19 vaccination stored in the Medicare Express app of the federal government.

According to the news report, the trial will involve around 500 volunteers, including those from aged care facilities and community clubs. 

The state government is currently obtaining vaccination information via the federal government’s Australian Immunisation Register; prior consent from residents will be secured to store their vaccination status in the app.

Based on a news report by the Australian Financial Review, the NSW government opted to pilot the app across the state’s regions instead of its capital Sydney to minimise the risk of infections spreading in hospitality venues. 


Fully vaccinated Australians can get their digital proof of vaccination via the Medicare Express app. Their COVID-19 digital vaccine certificate can also be added to their mobile wallets.

Last month, a software engineer found a bug in the Medicare app that could potentially lead to the creation of fake digital COVID-19 vaccine certificates. The federal agency has since acknowledged the report by Richard Nelson, who has taken part in research that previously unearthed flaws in the government’s contact tracing app COVIDSafe. 

Meanwhile, the federal government is also developing a smartphone app that can store digital vaccine certificates and test results. A tender for the digital health app was recently issued by the Australian Digital Health Agency. It is targeted to be introduced on iOS and Android devices by December.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
A Watch To Test The Icy Limits Of Antarctica thumbnail

A Watch To Test The Icy Limits Of Antarctica

On December 13, Simon Messner, the well-known Italian alpinist and film- maker, attempted his first marathon. It wasn’t on the foothills of the many mountains of Europe, Asia and the Americas that he is normally used to, but in ice-carpeted Antarctica. “Indeed, it is my first marathon, and in the Antarctica, the conditions are truly challenging!
Read More
尹 Received birthday congratulations from supporters "I was disciplined on my 60th birthday" thumbnail

尹 Received birthday congratulations from supporters “I was disciplined on my 60th birthday”

지지자 "내년엔 청와대에서" 말하기도 윤석열 국민의힘 대선후보의 지지자들이 18일 서울 여의도 국회를 찾았다. 윤 후보의 지지자 10여 명은 이날 오전 의원회관 앞에서 고깔모자를 쓰고 케이크와 꽃다발을 준비해 윤 후보를 맞이했다. 윤 후보는 이들을 보고 놀란 듯 "아이고 아침에 미역국도 안먹었는데"라고 말하기도 했다. 그는 지지자가 고깔모자를 건네자 "씌워주세요"라며 흔쾌히 머리를 내어줬다. 윤 후보는 연거푸 '감사하다' '고맙다'는…
Read More
Dupilumab Effective for Up To 1 Year in Teens With AD: Study thumbnail

Dupilumab Effective for Up To 1 Year in Teens With AD: Study

Serious adverse events remained rare and skin remained largely clear in adolescents treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis (AD) for up to 52 weeks in a phase 3 open-label extension trial, researchers reported. At 1 year, 86% of 50 remaining patients with weights under 60 kg (132 lb) had achieved 75% improvement (EASI-75;…
Read More
Index Of News